Ono R, Furihata K, Ichikawa Y, Nakazuru Y, et al. A phase 1 study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of danuglipron (PF-06882961), an oral small-molecule glucagon-like peptide-1 receptor agonist, in Japanese adults with type 2 diabetes mellitus. Diabetes Obes Metab 2022 Nov 26. doi: 10.1111/dom.14928.
PMID: 36433713